Asthma therapy with aerosols: Clinical relevance for the next decade

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 9, Issue 1, 1996, Pages 131-141

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

anticholinergics; asthma; glucocorticoids; 2 agonists

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOSPORIN A; FORMOTEROL; GLUCOCORTICOID; GOLD; IPRATROPIUM BROMIDE; METHOTREXATE; OXITROPIUM BROMIDE; SALBUTAMOL; SALMETEROL; TERBUTALINE SULFATE;

AEROSOL; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG MECHANISM; DYSPHONIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INHALATIONAL DRUG ADMINISTRATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; REVIEW;

EID: 0029924409     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1996.9.131     Document Type: Review

References (74)

1. AGERTOFT, L., and PEDERSEN, S. (1994). Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Rest. Med 5:369-372.
2. ANDERSON, S.D., SEALE, J.P., ROZEA, P., BANDLER, I., THEOBALD, G., and LINDSAY, D.A. (1976). Inhaled and oral salbutamol in exercise-induced asthma. Am. Rev. Respir. Dis. 114:493-500.
3. BARNES, P.J. (1992). New drugs for asthma. Eur. Respir. J. 5:1126-1136.
4. BARNES, P.J. (1993). Muscarinic receptor subtyes in airways. Life Sci. 52:521-528.
5. BARNES, P.J. (1995a). Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 152:838-860.
6. BARNES, P.J. (1995b). Cyclic nucleotides, phosphodiesterases and airway function. Eur. Respir. J. 5:457-462.
7. BARNES, P.J. (1995c). Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332:868-875.
8. BARNES, P.J., and ADCOCK, I.M. (1993). Anti-inflammatory actions of steroids: Molecular mechanisms. Trends Pharmacol. Sci. 14:436-441.
9. 2-agonists in asthma. Trends Pharmacol. Sci. 13:20-23.
10. 2-agonist and steroid dry powder inhaler in asthma. Am. J. Respir. Crit. Care Med. 151:1053-1057.
11. BARNES, P.J., and PEDERSEN, S. (1993). Efficacy and safety of inhaled steroids in asthma. Am. Rev. Respir. Dis. 148:S1-S26.
12. BARNES, P.J., CHUNG, K.F., and PAGE, C.P. (1988). Inflammatory mediators and asthma. Pharmacol. Rev. 40:49-84.
13. BARNES, P.J., BELVISI, M.G., MAK, J.C.W., HADDAD, E-B., and O'CONNOR, B. (1995). Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease. Life Sci. 56:853-859.
14. BARRETT, T.E., and STROM, B.L. (1995). Inhaled beta-adrenergic receptor agonists in asthma: More harm than good? Am. J. Respir. Crit. Care Med. 151:574-577.
15. BLACK, J.L., ARMOUR, C.L., JOHNSON, P.R.A., ALOUAN, L.A., and BARNES, P.J. (1990). The action of a potassium channel activator BRL 38227 (lemakalim) on human airway smooth muscle. Am. Rev. Respir. Dis. 142:1384-1389.
16. 2-agonists. Drugs 47:207-222.
17. BROWN, P.H., GREENING, A.P., and CROMPTON, G.K. (1993). Large volume spacer devices and the influence of high dose beclomethasone diproprionate on hypothalamo-pituitary-adrenal axis function. Thorax 48:233-238.
18. BUTCHERS, P.R., SKIDMORE, I.F., VARDEY, C.J., and WHEELDON, A. (1980). Characterisation of the receptor mediating antianaphylactic effects of beta-adrenoceptor agonists in human lung tissues in vitro. Br. J. Pharmacol. 71:663-667.
19. CARSTAIRS, J.R., NIMMO, A.J., and BARNES, P.J. (1985). Autoradiographic visualization of beta-adrenoceptor subtype in human lung. Am. Rev. Respir. Dis. 132:541-547.
20. CHANARIN, N., and JOHNSTON, S.L. (1994). Leukotrienes as a target in asthma therapy. Drugs 47:12-24.
21. CHEUNG, D., TIMMERS, M.C., ZWINDERMAN, A.H., BEL, E.H., DIJKMAN, J.H., and STERK, P.J. (1992). The prolonged effects of salmeterol on airway hyperresponsiveness in asthma. N. Engl. J. Med. 327:1198-1203.
22. COCKROFT, D., McPARRAND, C.P., BRITTO, S.A., SWYSTUN, V.A., and RUTHERFORD, C. (1993). Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342:833-837.
23. DEVALIA, J.L., SAPSFORD, R.J., RUSZNAK, C., TOUMBIS, M.J., and DAVIES, R.J. (1992). The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchialepithelial cells in vitro. Pulm. Pharmacol. 5:257-263.
24. DOMPELING, E., VAN SCHAYCK, C.P., MOLEMA, J., FOLGERING, H., VAN GRUSVEN, P.M., and VAN WEEL, C. (1992). Inhaled beclomethasone improves the course of asthma and COPD. Eur. Respir. J. 5:945-952.
25. ENGEL, T., HEINIG, J.H., MALLING, H.-J., SCHARING, B., NIKANDER, K., and MASDEN, F. (1989). Clinical comparison of inhaled budesonide delivered either by pressurized metered dose inhaler or Turbuhaler. Allergy 44:220-225.
26. EVANS, P.M., O'CONNOR, B.J., FULLER, R.W., BARNES, P.J., and CHUNG, K.F. (1993). Effect of inhaled corticosteroids on peripheral eosinophil counts and density profiles in asthma. J. Allergy Clin. Immunol. 91:643-649.
27. GIEMBYCZ, M.A. (1992). Could selective cyclic nucleotide phosphodiesterase inhibitors render bronchodilator therapy reundant in the treatment of bronchial asthma? Biochem Pharmacol. 43:2041-2051.
28. GREENING, A.P., IND, P.W., NORTHFIELD, M., and SHAW, G. (1994). Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344:219-224.
29. GROSS, N.J. (1988). Ipratropium bromide. N. Engl. J. Med. 319:486-494.
30. HAAHTELA, T., JÄRVINSEN, M., KAVA, T., et al. (1994). Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.
31. 3H]Ba 679, a slow-dissociating muscarinic receptor antagonist in human lung: Radioligand binding and autoradiographic mapping. Mol. Pharmacol. 45:899-907.
32. 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: Correlation with receptor autoradiography. Eur. J. Pharmacol. 206:133-138.
33. HILL, S.J., and TATTERSFIELD, A.E. (1995). Corticosteroid sparing agents in asthma. Thorax 50:577-582.
34. ISRAEL, E., RUBIN, P., KEMP, J.P., et al. (1993). The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma. Ann. Intern. Med. 119:1059-1066.
35. KELLOWAY, J.S., WYATT, R.A., and ADLIS, S.A. (1994). Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch. Intern. Med. 154:1349-1352.
36. KHARITONOV, S.A., YATES, D.H., and BARNES, P.J. (1996). Regular inhaled budesonide decreases nitric oxide concentration in the exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. (in press).
37. KIDNEY, J.C., FULLER, R.W., WORSDELL, Y-M., LAVENDER, E.A., CHUNG, K.F., and BARNES, P.J. (1993). Effect of an oral potassium channel activator BRL 38227 on airway function and responsiveness in asthmatic patients: Comparison with oral salbutamol. Thorax 48:130-134.
38. KWON, O.J., AU, B.T., COLLINS, P.D., et al. (1994). Tumor necrosis factor-induced interleukin 8 expression in cultured human epithelial cells. Am. J. Physiol. 11:L398-L405.
39. KWON, O.J., JOSE, P.J., ROBBINS, R.A., SCHALL, T.J., WILLIAMS, T.J., and BARNES, P.J. (1995). Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 12:488-496.
40. LIPWORTH, B.J. (1995). New perspectives in drug delivery and systemic bioactivity. Thorax 50:105-110.
41. MAESEN, F.P.V., SMEETS, J.J., COSTONGS, M.A.L., WALD, F.D.M., and CORNELISSEN, P.J.G. (1993). BA 679 Br, a new long-acting antimuscarinic bronchodilator: A pilot dose-escalation study. Eur. Respir. J. 6:1031-1036.
42. 2-adrenergic receptors in vivo. J. Clin. Invest. 96:99-106.
43. MITCHELL, J.A., BELVISI, M.G., AKARASEREEMOM, P., et al. (1994). Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: Regulation of dexamethasone. Br. J. Pharmacol. 113:1008-1014.
44. NELSON, H.S. (1995). Beta-adrenergic bronchodilators. N. Engl. J. Med 333:499-506.
45. NEWNHAM, D.M., McDEVITT, D.G., and LIPWORTH, B.J. (1994). Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma. Am. J. Med. 97:29-37.
46. 2-agonists. N. Engl. J. Med. 327:1204-1208.
47. 2-agonists. Am. J. Respir. Crit. Care Med. 150:381-387.
48. PATEL, H.J., BARNES, P.J., TAKAHASHI, T., TADJKARIMI, S., YACOUB, M.H., and BELVISI, M.G. (1995). Characterization of prejunctional muscarinic autoreceptors in human and guinea-pig trachea in vitro. Am. J. Respir. Crit Care. Med. 152:872-878.
49. PETERS, M.J., ADCOCK, I.M., BROWN, C.R., and BARNES, P.J. (1993). β-Agonist inhibition of steroid-receptor DNA binding activity in human lung. Am. Rev Respir. Dis. 147:A772.
50. PETERS, M.J., ADCOCK, I.M., BROWN, C.R., and BARNES, P.J. (1995). β-Adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur. J. Pharmacol. (Molec. Pharmacol. Section) 289:275-281.
51. RABE, K.F., JORRES, R., NOWAK, D., BEHR, N., and MAGNUSSEN, H. (1993). Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am. Rev. Respir. Dis. 147:1436-1441.
52. 2-adrenoceptors. J. Appl. Physiol. 65:700-705.
53. ROBBINS, R.A., BARNES, P.J., SPRINGALL, D.R., et al. (1994). Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem. Biophys. Res. Commun. 203:209-218.
54. SCHLEIMER, R.P. ( 1990). Effects of glucocorticoids on inflammatory cells relevant to their therapeutic application in asthma. Am. Rev. Respir. Dis. 141:S59-S69.
55. SEARS, M.R., TAYLOR, D.R., PRINT, C.G., et al. (1990). Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336:1391-1396.
56. SELROOS, O., and HALME, M. (1991). Effect of a Volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered-dose inhaler and dry powder inhaler. Thorax 46:891-894.
57. SELROOS, O., BACKMAN, R., FORSEN, K-O., et al. (1994). When to start treatment of asthma with inhaled steroids? Eur. Respir. J. 7(Suppl. 18):151S.
58. SOUSA, A.R., POSTON, R.N., LANE, S.J., NARHOSTEEN, J.A., and LEE, T.H. (1993). Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am. Rev. Respir. Dis. 147:1557-1561.
59. SPECTOR, S.L., SMITH, L.J., and GLASS, M. (1994). Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist in subjects with bronchial asthma. Am. J. Respir. Crit. Care Med. 150:618-623.
60. SPITZER, W.O., SUISSA, S., ERNST, P., et al. (1992). The use of β-agonists and the rate of death and near-death from asthma. N. Engl. J. Med. 326:503-506.
61. STEVENS, D.A., BARNES, P.J., and ADCOCK, I.M. (1995). β-Agonists inhibit DNA binding of glucocorticoid receptors in human pulmonary and bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 151:A195.
62. SUISSA, S., ERNST, P., BOlVIN, J-F., et al. (1994). A cohort analysis of excess mortality in asthma due to use of inhaled β-agonists. Am. J. Respir. Crit. Care Med. 149:604-610.
63. TAKAHASHI, T., BELVISI, M.G., PATEL, H., et al. (1994). Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea-pig and human airways. Am. J. Respir. Crit. Care Med. 150:1640-1645.
64. TAMAOKI, J., CHIYOTANI, A., TAGAYA, E., SAKAI, N., and KONNO, K. (1994). Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and dif-fuse panbronchiolitis. Thorax 49:545-548.
65. THORSSON, L., EDSBÄCKER, S., and CONRADSON, T-B. (1994). Lung deposition of budesonide from Turbohaler R is twice that from a pressurized metered-dose inhaler pMDI. Eur. Respir. J. 7:1839-1844.
66. TORPHY, T.J., and UNDEM, R.J. (1991). Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46:512-523.
67. ULRIK, C.S., and KOK-JENSEN, A. (1994). Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic. Eur Respir. J. 7:1003-1005.
68. VAN DE STOLPE, A., CALDENHOVEN, E., RAAIJMAKERS, J.A.M., VAN DER SAAG, P.T., and KOENDORMAN, L. (1993). Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am. J. Respir Cell Mol. Biol. 8:340-347.
69. WILLIAMSON, I.J., MATUSIEWICZ, S.P., BROWN, P.H., GREENING, A.P., and CROMPTON, G.K. (1995). Frequency of voice problems and cough in patients using pressurised aerosol inhaled steroid preparations. Eur. Respir. J. 8:590-592.
70. WOOLCOCK, A., LUNDBACK, B., RINGDAL, O.L.N., and JACQUES, L.A. (1994). Comparison of the effect of addition of salmeterol with doubling the inhaled steroid dose in asthmatic patients. Am. J. Respir. Crit. Care Med. 149:A280.
71. WOOLLEY, M.J., DENBURG, J.A., ELLIS, R., DAHLBACK, M., and O'BYRNE, P.M. (1994). Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am. J. Respir. Cell Mol. Biol. 11:600-606.
72. WRIGHT, L.C., CAMMISULI, S., BABOULENE. L., FOZZARD, J., ADCOCK, I.M., and BARNES, P.J. (1995). Cyclosporin A and glucocorticoids interact synergistically in T lymphocytes: Implications for asthma therapy. Am. J. Respir. Crit. Care Med. 151:A675.
73. YATES, D.H., WORSDELL, M., SUSSMAN, H., SHAW, M., BARNES, P.J., and CHUNG, K.F. (1995a). Regular formoterol treatment in mild asthma: Effect on bronchial reactivity during and after treatment. Am. J. Respir. Crit. Care Med. 152:1170-1174.
74. YATES, D.H., KHARITONOV, S.A., WORSDELL, M., SCOTT, D.M., and BARNES, P.J. (1995b). Effect of regular inhaled budesonide on tolerance induced by salmeterol to the acute bronchoprotective effect of salbuterol. Am. J. Respir. Crit. Care Med. 151:A40.